Showing 1 - 10 results of 10 for search 'Carsten Niemann', query time: 0.04s
Refine Results
-
1
-
2
-
3
PB2706: NO DIFFERENCE IN SURVIVAL OUTCOMES BETWEEN IMMIGRANTS AND DANISH-BORN CITIZENS WITH A HEMATOLOGICAL MALIGNANCY: A NATIONWIDE, POPULATION-BASED REGISTER STUDY by Joachim Baech, Lasse Jakobsen, Marianne Severinsen, Mikkel Runason Simonsen, Henrik Frederiksen, Carsten Niemann, Judit Jørgensen, Søren Johnsen, Tarec El-Galaly
Published 2023-08-01
Article -
4
P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA by Christian Brieghel, Morten Nørgaard Andersen, Nicolai Grønne Jørgensen, Trine Silkjær, Thomas Lund, Maja Hinge, Henrik Gregersen, Robert Schou Pedersen, Agoston Szabo, Carsten Niemann
Published 2023-08-01
Article -
5
P620: GENETIC ALTERATIONS AND OUTCOMES WITH FIXED-DURATION IBRUTINIB+VENETOCLAX (IBR+VEN): RESULTS FROM THE PHASE 3 GLOW STUDY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL by Arnon Kater, Brandon Hodkinson, Carol Moreno, Talha Munir, Mark-David Levin, Carsten Niemann, Keqin Qi, Pierre Sinet, Kurt Baeten, Donne Bennett Caces, Srimathi Srinivasan
Published 2023-08-01
Article -
6
P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL by Carsten Niemann, Mark-David Levin, Anders Österborg, Jeanette Lundin, Magdalena Kättström, Jeanette Vollerup, Caspar Da Cunha-Bang, Michael Foraux, Christian Brieghel, Fransien de Boer, Lisbeth Enggaard, Christian Bjorn Poulsen, Joanne Reekie, Rudi Agius
Published 2023-08-01
Article -
7
S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STATUS FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB + VENETOCLAX IN THE HOVON 141/VISION TRIAL by Aleksandra Urban, Johanne Hermansen, Yanping Yin, Weikaixin Kong, Rebecca Teglgaard, Christian Brieghel, Sabina Kersting, Geir E. Tjønnfjord, Mark-David Levin, Hoa T. T. Tran, Mattias Mattsson, Juha Ranti, Gerrit-Jan Veldhuis, Caspar Da Cunha-Bang, Rogier Mous, Julie Dubois, Arnon Kater, Carsten Niemann, Tero Aittokallio, Sigrid Skånland
Published 2023-08-01
Article -
8
S148: TIME-LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CLL WHO HAVE UNDETECTABLE MRD – 4-YEAR FOLLOW UP FROM THE RANDOMIZED PHASE II VISION/HO141 TRIAL by Arnon Kater, Julie Dubois, Christian Brieghel, Sabina Kersting, Lisbeth Enggaard, Gerrit Veldhuis, Rogier Mous, Clemens Mellink, Johan Dobber, Christian Poulsen, Caspar Da Cunha-Bang, Hendrik Fredriksen, Ann Janssens, Ida Schjodt, Ellen Dompeling, Juha Ranti, Mattias Mattsson, Mar Bellido, Hoa Tran, Kazem Nasserinejad, Mark-David Levin, Carsten Niemann
Published 2023-08-01
Article -
9
S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY by Othman Al-Sawaf, Sandra Robrecht, Can Zhang, Stefano Olivieri, Yi Meng Chang, Anna-Maria Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Karl-Anton Kreuzer, Liliya Sivcheva, Carsten Niemann, Anthony Schwarer, Javier Loscertales Pueyo, Robert Weinkove, Dirk Strumberg, Allanah Kilfoyle, Eva Runkel, Barbara Eichhorst, Stephan Stilgenbauer, Yanwen Jiang, Michael Hallek, Kirsten Fischer
Published 2023-08-01
Article -
10
P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB-VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON... by Sabina Kersting, Mark-David Levin, Julie Dubois, Yvette van Norden, Johan Dobber, Yvonne Jauw, Anne-Marie van der Kevie-Kersemaekers, Clemens Mellink, Caspar Da Cunha-Bang, Leonie Van Desr Burg, Doreen Te Raa, Fransien de Boer, Jolanda Droogendijk, Cecile Idink, Koen De Heer, Marten Nijziel, Lidwine Tick, Inge Ludwig, Mathijs Silbermann, Aart Beeker, Mar Bellido, Ludo Evers, Gerben Zwezerijnen, Josée Zijlstra, Marcel Kap, Carsten Niemann, Arnon Kater
Published 2023-08-01
Article